Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Occlusion Perfusion Catheter for Optimal Delivery of Paclitaxel for the Prevention of Endovascular Restenosis - Below the Knee

NCT02395744 is registered in ClinicalTrials.gov with Horizons International Peripheral Group as lead sponsor.

NCT NCT02395744
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02395744 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Occlusion Perfusion Catheter for Optimal Delivery of Paclitaxel for the Prevention of Endovascular Restenosis - Below the Knee
Lead sponsor
Horizons International Peripheral Group
Phase
Not applicable
Overall status
Completed
Start date
March 11, 2015
Completion date
February 23, 2017
Enrollment
11 (actual)
Sites
4

Conditions

As the registry lists them; a condition with its own page is linked.

arterial occlusive diseases, cardiovascular diseases, critical limb ischemia, peripheral arterial disease, peripheral vascular disease